1629229-37-3,MFCD30532641
Catalog No.:AA01EO9F

1629229-37-3 | Fezolinetant

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$145.00   $101.00
- +
10mg
≥98%
in stock  
$275.00   $192.00
- +
25mg
≥98%
in stock  
$650.00   $455.00
- +
50mg
≥98%
in stock  
$1,228.00   $859.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01EO9F
Chemical Name:
Fezolinetant
CAS Number:
1629229-37-3
Molecular Formula:
C16H15FN6OS
Molecular Weight:
358.3933
MDL Number:
MFCD30532641
SMILES:
Fc1ccc(cc1)C(=O)N1CCn2c([C@H]1C)nnc2c1snc(n1)C
Properties
Computed Properties
 
Complexity:
505  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.6  

Downstream Synthesis Route

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

1383146-20-0   
(R)-(4-fluorophenyl)-(8-methyl-3-(3-(methyl)-1,2,4-thiadiazol-5-yl)-5,6-dihydro-1,2,4triazolo4,3-apyrazin-7(8H)-yl)methanone 

[1]ACSMedicinalChemistryLetters,2015,vol.6,p.736-740

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-US2021/94955,2021,A1Locationinpatent:Paragraph0087-0091

Literature

Title: Fraser GL, et al. The NK3 Receptor Antagonist ESN364 Interrupts Pulsatile LH Secretion and Moderates Levels of Ovarian Hormones Throughout the Menstrual Cycle. Endocrinology. 2015 Nov;156(11):4214-25.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1629229-37-3
Tags:1629229-37-3 Molecular Formula|1629229-37-3 MDL|1629229-37-3 SMILES|1629229-37-3 Fezolinetant
Catalog No.: AA01EO9F
1629229-37-3,MFCD30532641
1629229-37-3 | Fezolinetant
Pack Size: 5mg
Purity: ≥98%
in stock
$145.00 $101.00
Pack Size: 10mg
Purity: ≥98%
in stock
$275.00 $192.00
Pack Size: 25mg
Purity: ≥98%
in stock
$650.00 $455.00
Pack Size: 50mg
Purity: ≥98%
in stock
$1,228.00 $859.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01EO9F
Chemical Name: Fezolinetant
CAS Number: 1629229-37-3
Molecular Formula: C16H15FN6OS
Molecular Weight: 358.3933
MDL Number: MFCD30532641
SMILES: Fc1ccc(cc1)C(=O)N1CCn2c([C@H]1C)nnc2c1snc(n1)C
Properties
Complexity: 505  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 25  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.6  
Downstream Synthesis Route
1429558-79-1    1629229-37-3 

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

1383146-20-0   
(R)-(4-fluorophenyl)-(8-methyl-3-(3-(methyl)-1,2,4-thiadiazol-5-yl)-5,6-dihydro-1,2,4triazolo4,3-apyrazin-7(8H)-yl)methanone 

[1]ACSMedicinalChemistryLetters,2015,vol.6,p.736-740

1682610-44-1    403-43-0    1629229-37-3 

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

1429560-52-0    1629229-37-3 

[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]

75-75-2    1629229-37-3    2306217-21-8 

[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-US2021/94955,2021,A1Locationinpatent:Paragraph0087-0091

Building Blocks More >
1314873-02-3
1314873-02-3
BPO-27 racemate
AA01EOFT | MFCD30532675
23827-91-0
23827-91-0
[Des-Arg9]-Bradykinin acetate
AA01EOKJ | MFCD00236892
1015073-42-3
1015073-42-3
PSI-7409
AA01EOQ4 | MFCD28386293
5537-19-9
5537-19-9
1-(4-methoxyphenyl)-2-(1-pyrrolidinyl)-1-pentanone,monohydrochloride
AA01EOZ3
208445-06-1
208445-06-1
8-bromo-guanosinecyclic3',5'-[(R)-(hydrogenphosphorothioate)],monosodiumsalt
AA01EP9Z | MFCD04037242
1435727-11-9
1435727-11-9
(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-d3-morphinan-3,6,14-triol
AA01EPHR
330819-85-7
330819-85-7
6,7-dihydro-2-(methylthio)-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-amine
AA01EPMG | MFCD00698485
226956-06-5
226956-06-5
cyclo(D-alanyl-D-tryptophyl-4-aminobutanoyl-D-alanyl-D-valyl-L-phenylalanyl-D-valyl)
AA01EPTO
95497-55-5
95497-55-5
9Z,11E,13Z-octadecatrienoicacid,methylester
AA01EQ3V | MFCD05864135
2055050-87-6
2055050-87-6
8-chloro-2,5-dihydro-2-(3-methoxyphenyl)-3H-pyrazolo[4,3-c]quinolin-3-one
AA01EQ9S | MFCD31922710
Submit
© 2017 AA BLOCKS, INC. All rights reserved.